Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, October, 2009, Advertising

New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive

New pharmaceutical account wins notified to us by the winning agency for the period August to October 2009 inclusive:

       

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AAH (UK) N/A Corporate Euro RSCG Life
GSK UK Eumovate and Eumocream Dermatology Euro RSCG Life
Johnson & Johnson EMA Vision care Ophthalmology Euro RSCG Life
Lundbeck Cipralex Mental health MSA Digital
Lundbeck Ebixa Central nervous system MSA Digital
Merck-Serono Global N/A Fertility portfolio Euro RSCG Life
Mundipharma International  New product  Respiratory  Health 4 Brands 
Mundipharma International   New product  Pain  Health 4 Brands  
Novo Nordisk  Levemir  Diabetes  Bedgebury Communications 
Takeda  Amias  Cardiovascular  MSA Digital 
Teva  Qvar  Respiratory  MSA Digital 
Teva Nasofan Allergies MSA Digital


Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

16th November 2009

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics